MTHFD2 inhibition has been shown to enhance the apoptotic effects of methotrexate (MTX; another antifolate that has a similar mechanism to pemetrexed) in several cancer cell lines18, and appeared to be a rational selection for further study. Here, MTHFD2 is linked to cancer.